Q- and L-type calcium channels control the development of calbindin phenotype in hippocampal pyramidal neurons in vitro

Eur J Neurosci. 2000 Jun;12(6):2068-78. doi: 10.1046/j.1460-9568.2000.00105.x.

Abstract

Cultured immature hippocampal neurons from embryonic 17-day-old rats were used to explore activity-dependent regulation of neuronal phenotype differentiation in the developing hippocampus. The calbindin-D28k phenotype of the pyramidal neurons appeared during the first 6 days in culture, and was expressed by 12% of the cells on day 6. Daily stimulation with 50 mM KCl during the first 5 days in vitro increased the number of calbindin-D28k-positive pyramidal neurons without affecting neuronal survival. This effect was prevented by buffering extracellular Ca2+. Omega-agatoxin-IVA-sensitive Q-type and nitrendipine-sensitive L-type voltage-gated Ca2+ channels (VGCCs) carried Ca2+ currents and Ca2+ influx in immature pyramidal neurons at somata level. Blockade of these channels inhibited calbindin-D28k phenotype induced by 50 mM KCl. Conversely, glutamate-activated Ca2+ channel antagonists did not affect the KCl-induced calbindin-D28k phenotype. Chronic blockade of Q- and/or L-type VGCCs downregulated the normal calbindin-D28k development of immature pyramidal neurons without affecting neuronal survival, the somatic area of pyramidal neurons or the number of GABAergic-positive (gamma-aminobutyric acid) interneurons. However, at later developmental stages, Q-type VGCCs lost their ability to control Ca2+ influx at somata level, and both Q- and L-type VGCCs failed to regulate calbindin-D28k phenotype. These results suggest that Q-type channels, which have been predominantly associated with neurotransmitter release in adult brain, transiently act in synergy with L-type VGCCs to direct early neuronal differentiation of hippocampal pyramidal neurons before the establishment of their synaptic circuits.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calbindin 1
  • Calbindins
  • Calcium / pharmacokinetics
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels, L-Type / physiology*
  • Calcium Channels, Q-Type / physiology*
  • Cell Differentiation / drug effects
  • Cell Differentiation / physiology
  • Cells, Cultured
  • Female
  • Gene Expression Regulation, Developmental / physiology
  • Glutamic Acid / pharmacology
  • Hippocampus / cytology
  • Nitrendipine / pharmacology
  • Phenotype
  • Potassium Chloride / pharmacology
  • Pregnancy
  • Pyramidal Cells / chemistry
  • Pyramidal Cells / cytology
  • Pyramidal Cells / physiology*
  • Rats
  • Rats, Sprague-Dawley
  • S100 Calcium Binding Protein G / genetics*
  • gamma-Aminobutyric Acid / genetics
  • omega-Agatoxin IVA / pharmacology
  • omega-Conotoxin GVIA / pharmacology

Substances

  • Calb1 protein, rat
  • Calbindin 1
  • Calbindins
  • Calcium Channel Blockers
  • Calcium Channels, L-Type
  • Calcium Channels, Q-Type
  • S100 Calcium Binding Protein G
  • omega-Agatoxin IVA
  • Glutamic Acid
  • gamma-Aminobutyric Acid
  • Potassium Chloride
  • omega-Conotoxin GVIA
  • Nitrendipine
  • Calcium